Headline,Multiplier
[Stock] Fails Phase 3 Drug Trials," Drug Rejected by FDA,0.5"
[Stock] Gets Exclusive Rights to Vaccine Distribution,2.0
[Stock] Gets FDA Approval for Groundbreaking Alzheimer's Drug,3.0
[Stock] Enters Pharmaceutical Market with New Acquisition,1.3
[Stock] Reveals Promising Results from Early Stage Drug Trials,1.8
[Stock] Announces Successful Trials of Revolutionary Cancer Drug,2.5
[Stock] Reveals Plan to Invest Heavily in R&D,1.2
